Argenx Se (ARGX) Accounts Payables (2015 - 2026)

Argenx Se (ARGX) posted quarterly Accounts Payables of $1.5 billion for Q2 2026, down 99.85% year-on-year from $1016.2 billion in Q2 2025, and up 19.57% on a QoQ basis from $1.3 billion in Q4 2025.

Argenx Se (ARGX) Accounts Payables (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Accounts Payables for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

  • Quarterly Accounts Payables fell 99.85% year-over-year to $1.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (down 99.85% YoY) and the FY2025 annual result came in at $1.3 billion, up 94.93% from the prior year.
  • Accounts Payables grew to $1.5 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Over the last five years, Accounts Payables for ARGX reached as high as $1016.2 billion in Q2 2025 and fell as low as $257.7 million in Q2 2022.
  • A 5-year average of $113.5 billion and a median of $479.8 million in 2024 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2025 — Accounts Payables surged 211675.45% — and 2026, when it tumbled 99.85%.
  • Year by year, Accounts Payables stood at $295.7 million in 2022, then soared by 40.02% to $414.0 million in 2023, then jumped by 57.0% to $650.0 million in 2024, then soared by 94.93% to $1.3 billion in 2025, then grew by 19.57% to $1.5 billion in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $1.5 billion, $1.3 billion, and $1016.2 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 126.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Bn
Dec 31, 2025 1.27 Bn
Jun 30, 2025 1,016.16 Bn
Dec 31, 2024 649.99 Mn
Jun 30, 2024 479.83 Mn
Dec 31, 2023 414.01 Mn
Jun 30, 2023 309.99 Mn
Dec 31, 2022 295.68 Mn
Jun 30, 2022 257.69 Mn
Dec 31, 2021 293.42 Mn
Jun 30, 2021 239.44 Mn
Dec 31, 2020 255.20 Mn
Jun 30, 2020 145.49 Mn
Dec 31, 2019 97.07 Mn
Jun 30, 2019 62.66 Mn
Dec 31, 2018 42.19 Mn
Jun 30, 2018 31.11 Mn
Dec 31, 2017 22.06 Mn
Jun 30, 2017 18.86 Mn
Dec 31, 2016 17.59 Mn